Survival benefits of adjuvant chemotherapy with oral doxifluridine (5′-DFUR) following radiotherapy in patients with unresectable pancreatic cancer

Journal of Surgical Oncology

Volumn 78, Issue 3, 2001, Pages 202-207

  Tsuruta, Koji ^a   Okamoto, Astutake ^a   Egawa, Naoto ^a   Kamisawa, Terumi ^a   Karasawa, Katsuyuki ^a   Takahashi, Toshio ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Doxifluridine (5 DFUR); Kinetics of CA19 9; Long term survival; Radiotherapy; Thymidine phosphorylase; Unresectable pancreatic cancer

Indexed keywords

DOXIFLURIDINE; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BYPASS SURGERY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADMINISTRATION, ORAL; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLOXURIDINE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVORS;

EID: 0034762705     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.1151     Document Type: Article

References (21)

1. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer
2. Comparative therapeutic trial of radiation with and without chemotherapy in pancreatic cancer
3. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts
4. Comparative antitumor activity of 5-fluorouracil and 5′-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma
5. External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer
6. Intraoperative radiotherapy in the combined-modality management of pancreatic cancer
7. Intraoperative radiation therapy of pancreatic carcinoma: A report of RTOG-8505
8. Pancreatic cancer: Treatment with neutron irradiation alone and with chemotherapy
9. Concomitant intraarterial cisplatin, intravenous 5-fluorouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: A phase 2 study of the Puget Sound Oncology Consortium (PSOC-703)
10. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas
11. Combined modality therapy for stage 2 and stage 3 pancreatic carcinoma
12. Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma
13. Phase 1 trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas
14. Combined chemoradiotherapy for unresectable pancreatic cancer
15. CA19-9: A predictor of response in pancreatic cancer treated with gemcitabine and cisplatin
16. Intraoperative electron beam radiation therapy (IOEBRT) for carcinoma of exocrine pancreas
17. Antitumor activity of 5′-deoxy-5-fluororidine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs
18. Clinical phase II study of 5′-DFUR for cancer of the digestive organs by a cooperative study group
19. Phase II study of 5′-deoxy-5-fluorouridine (5′-DFUR) on patients with malignant cancer: Multi-institutional cooperative study
20. Prolonged oral versus high-dose intravenous etoposide in combination with carboplatin for stage 4 non-small-cell lung cancer (NSCLC): A randomized trial
21. Novel oral fluoropyrimidines in treatment of metastatic colorectal cancer